• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Geneia Partners with Covidien to Enter $21B Remote Patient Monitoring Market

by Jasmine Pennic 09/04/2014 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

geneia

Geneia today announced a multi-year, strategic partnership with Covidien to help improve the health of and reduce the costs for chronically ill patients.  The partnership  with Covidien has agreed to provide Geneia with rights to sell its ZephyrLIFE remote patient monitoring solutions in designated markets to monitor patients with heart disease, diabetes, and other chronic illnesses in the home setting.  

Geneia’s @home product combines Covidien’s ZephyrLIFE remote monitoring technology with Geneia’s clinical care expertise to better manage chronic and acute conditions.  Patients use the @home remote monitoring device to record their vital signs on a daily basis, including weight, pulse, blood pressure, blood oxygen level, and blood glucose.  Geneia merges this patient data with administrative and clinical data sets to provide an early warning about patients at risk and trigger the deployment of early intervention strategies such as telephonic support and home visits by clinicians.  As a result, @home is able to: 

  • Reduce hospital admissions/readmissions, observation bed days, and emergency department visits,
  • Ensure appropriate medication usage,
  • Improve adherence to recommended preventive care, 
  • Improve coordination of care between the patient and their physician(s); and 
  • Enable and engage patients and the people in their support system to participate in managing their health and well-being.

Geneia also announced that Capital BlueCross, a $3 billion health plan with over 700,000 members, is the first of the Blue plans to pilot @home to monitor patients with congestive heart failure.  “At Capital BlueCross, our members afflicted with congestive heart failure are among the sickest and costliest members we have. We’re confident that @home will improve the health outcomes and reduce hospital readmissions for these members,” said Dr. Jennifer Chambers, Senior Vice President and Chief Medical Officer of Capital BlueCross. 

This service is now available to other Blue plans and insurance carriers across the country as a value-add service to chronically ill patients.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

White House Event Unveils CMS Health Tech Ecosystem Initiative

White House Event Unveils CMS Health Tech Ecosystem Initiative

Meaningful Use Penalties_Meaningful Use_Partial Code Free_Senators Urge CMS to Establish Clear Metrics for ICD-10 Testing

CMS Finalizes TEAM Model: A New Era of Value-Based Surgical Care

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low, But AI Dominates and $1B+ IPOs Emerge

Healthcare Investment Shifts in 1H 2025: AI Remains a Bright Spot Amidst Fundraising Decline

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low

Digital Health Faces Q2’25 Pullback: Funding Falls to 5-Year Low

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Health IT Sector Navigates Policy Turbulence with Resilient M&A

Health IT’s New Chapter: IPOs Return, Resilient M&A, Valuations Rise in 1H 2025

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |